Paper445419
Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents.
Guarino AM and 7 others. Cancer Res, 1979. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents. Papers, record 445419. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/445419
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Drug Evaluation | Major topic |
| Drug Evaluation, Preclinical | Major topic |
| Animals | |
| Humans | |
| Lethal Dose 50 | |
| Mice | |
| Research Design | |
| Species Specificity |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30712196 | S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells. | Breast Cancer Res Treat | 2019 | https://conductscience.org/library/papers/30712196 | PubMed |
| 16222783 | Modelling and simulation in the development and use of anti-cancer agents: an underused tool? | J Pharmacokinet Pharmacodyn | 2004 | https://conductscience.org/library/papers/16222783 | PubMed |
| 8137461 | Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylates. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8137461 | PubMed |
| 7460195 | Adriamycin and daunomycin dose-dependent effects upon contractions of isolated rat myocytes. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/7460195 | PubMed |
| 7397944 | Antitumor drug toxicity in tumor-free and tumor-bearing mice. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/7397944 | PubMed |
| 7389061 | Evaluation of antitumor drug side effects in small animals. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/7389061 | PubMed |
| 7105379 | Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7105379 | PubMed |
| 2293914 | Combination chemotherapy with cisplatin and nifedipine: synergistic antitumor effects against a cisplatin-resistant subline of the B16 amelanotic melanoma. | Clin Exp Metastasis | 1990 | https://conductscience.org/library/papers/2293914 | PubMed |
| 1464163 | Choice of starting dose and escalation for phase I studies of antitumor agents. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1464163 | PubMed |
| 116778 | Mouse and large-animal toxicology studies of twelve antitumor agents: relevance to starting dose for phase I clinical trials. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/116778 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/445419
GET https://conductscience.org/api/papers/v1/445419/authors